ERLYSION Trademark

Trademark Overview

On Friday, December 21, 2018, a trademark application was filed for ERLYSION with the United States Patent and Trademark Office. The USPTO has given the ERLYSION trademark a serial number of 88239106. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 18, 2022. This trademark is owned by JOHNSON & JOHNSON. The ERLYSION trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of oncological diseases and disorders
erlysion

General Information

Serial Number88239106
Word MarkERLYSION
Filing DateFriday, December 21, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 18, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2019

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Monday, July 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 18, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 3, 2021SOU EXTENSION 5 GRANTED
Wednesday, November 24, 2021SOU EXTENSION 5 FILED
Friday, December 3, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 24, 2021TEAS EXTENSION RECEIVED
Wednesday, November 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 20, 2021SOU EXTENSION 4 GRANTED
Tuesday, April 20, 2021SOU EXTENSION 4 FILED
Tuesday, April 20, 2021TEAS EXTENSION RECEIVED
Thursday, November 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 17, 2020SOU EXTENSION 3 GRANTED
Tuesday, November 17, 2020SOU EXTENSION 3 FILED
Tuesday, November 17, 2020TEAS EXTENSION RECEIVED
Saturday, May 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 7, 2020SOU EXTENSION 2 GRANTED
Thursday, May 7, 2020SOU EXTENSION 2 FILED
Thursday, May 7, 2020TEAS EXTENSION RECEIVED
Thursday, December 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2019SOU EXTENSION 1 GRANTED
Tuesday, December 3, 2019SOU EXTENSION 1 FILED
Tuesday, December 3, 2019TEAS EXTENSION RECEIVED
Tuesday, June 11, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 16, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 7, 2019ASSIGNED TO EXAMINER
Tuesday, January 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 25, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

erlysion diseases disorders oncological treatment preparations pharmaceutical